vs
欧加隆（OGN）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
欧加隆的季度营收约是Rollins, Inc.的1.7倍（$1.5B vs $906.4M），Rollins, Inc.净利率更高（11.9% vs -13.6%，领先25.5%），Rollins, Inc.同比增速更快（10.2% vs -5.3%），Rollins, Inc.自由现金流更多（$111.2M vs $96.0M），过去两年Rollins, Inc.的营收复合增速更高（0.8% vs -3.6%）
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
OGN vs ROL — 直观对比
营收规模更大
OGN
是对方的1.7倍
$906.4M
营收增速更快
ROL
高出15.5%
-5.3%
净利率更高
ROL
高出25.5%
-13.6%
自由现金流更多
ROL
多$15.2M
$96.0M
两年增速更快
ROL
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $906.4M |
| 净利润 | $-205.0M | $107.8M |
| 毛利率 | 49.2% | — |
| 营业利润率 | -9.8% | 16.1% |
| 净利率 | -13.6% | 11.9% |
| 营收同比 | -5.3% | 10.2% |
| 净利润同比 | -288.1% | 2.5% |
| 每股收益（稀释后） | $-0.78 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OGNROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.5B | $912.9M | ||
| Q3 25 | $1.6B | $1.0B | ||
| Q2 25 | $1.6B | $999.5M | ||
| Q1 25 | $1.5B | $822.5M | ||
| Q4 24 | $1.6B | $832.2M | ||
| Q3 24 | $1.6B | $916.3M | ||
| Q2 24 | $1.6B | $891.9M |
净利润OGNROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $-205.0M | $116.4M | ||
| Q3 25 | $160.0M | $163.5M | ||
| Q2 25 | $145.0M | $141.5M | ||
| Q1 25 | $87.0M | $105.2M | ||
| Q4 24 | $109.0M | $105.7M | ||
| Q3 24 | $359.0M | $136.9M | ||
| Q2 24 | $195.0M | $129.4M |
毛利率OGNROL
| Q1 26 | — | — | ||
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — |
营业利润率OGNROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | -9.8% | 17.5% | ||
| Q3 25 | 15.2% | 21.9% | ||
| Q2 25 | 14.4% | 19.8% | ||
| Q1 25 | 6.7% | 17.3% | ||
| Q4 24 | 8.1% | 18.1% | ||
| Q3 24 | 13.1% | 20.9% | ||
| Q2 24 | 14.6% | 20.4% |
净利率OGNROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | -13.6% | 12.8% | ||
| Q3 25 | 10.0% | 15.9% | ||
| Q2 25 | 9.1% | 14.2% | ||
| Q1 25 | 5.8% | 12.8% | ||
| Q4 24 | 6.8% | 12.7% | ||
| Q3 24 | 22.7% | 14.9% | ||
| Q2 24 | 12.1% | 14.5% |
每股收益（稀释后）OGNROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $-0.78 | $0.24 | ||
| Q3 25 | $0.61 | $0.34 | ||
| Q2 25 | $0.56 | $0.29 | ||
| Q1 25 | $0.33 | $0.22 | ||
| Q4 24 | $0.42 | $0.22 | ||
| Q3 24 | $1.38 | $0.28 | ||
| Q2 24 | $0.75 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $574.0M | $116.5M |
| 总债务越低越好 | $8.6B | $650.6M |
| 股东权益账面价值 | $752.0M | $1.4B |
| 总资产 | $12.9B | $3.2B |
| 负债/权益比越低杠杆越低 | 11.49× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资OGNROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | $574.0M | $100.0M | ||
| Q3 25 | $672.0M | $127.4M | ||
| Q2 25 | $599.0M | $123.0M | ||
| Q1 25 | $547.0M | $201.2M | ||
| Q4 24 | $675.0M | $89.6M | ||
| Q3 24 | $763.0M | $95.3M | ||
| Q2 24 | $704.0M | $106.7M |
总债务OGNROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | $8.6B | $486.1M | ||
| Q3 25 | $8.8B | $485.7M | ||
| Q2 25 | $8.9B | $485.3M | ||
| Q1 25 | $9.0B | $485.5M | ||
| Q4 24 | $8.9B | $395.3M | ||
| Q3 24 | $8.7B | — | ||
| Q2 24 | $8.7B | — |
股东权益OGNROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $752.0M | $1.4B | ||
| Q3 25 | $906.0M | $1.5B | ||
| Q2 25 | $733.0M | $1.4B | ||
| Q1 25 | $542.0M | $1.4B | ||
| Q4 24 | $472.0M | $1.3B | ||
| Q3 24 | $493.0M | $1.3B | ||
| Q2 24 | $144.0M | $1.2B |
总资产OGNROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $12.9B | $3.1B | ||
| Q3 25 | $13.6B | $3.2B | ||
| Q2 25 | $13.5B | $3.2B | ||
| Q1 25 | $13.2B | $2.9B | ||
| Q4 24 | $13.1B | $2.8B | ||
| Q3 24 | $12.8B | $2.8B | ||
| Q2 24 | $12.2B | $2.8B |
负债/权益比OGNROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | 11.49× | 0.35× | ||
| Q3 25 | 9.74× | 0.32× | ||
| Q2 25 | 12.14× | 0.34× | ||
| Q1 25 | 16.52× | 0.36× | ||
| Q4 24 | 18.81× | 0.30× | ||
| Q3 24 | 17.75× | — | ||
| Q2 24 | 60.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $141.0M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $96.0M | $111.2M |
| 自由现金流率自由现金流/营收 | 6.4% | 12.3% |
| 资本支出强度资本支出/营收 | 3.0% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | $538.0M | $621.1M |
8季度趋势，按日历期对齐
经营现金流OGNROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $141.0M | $164.7M | ||
| Q3 25 | $264.0M | $191.3M | ||
| Q2 25 | $220.0M | $175.1M | ||
| Q1 25 | $75.0M | $146.9M | ||
| Q4 24 | $390.0M | $188.2M | ||
| Q3 24 | $141.0M | $146.9M | ||
| Q2 24 | $332.0M | $145.1M |
自由现金流OGNROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $96.0M | $159.0M | ||
| Q3 25 | $218.0M | $182.8M | ||
| Q2 25 | $181.0M | $168.0M | ||
| Q1 25 | $43.0M | $140.1M | ||
| Q4 24 | $335.0M | $184.0M | ||
| Q3 24 | $99.0M | $139.4M | ||
| Q2 24 | $300.0M | $136.4M |
自由现金流率OGNROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 6.4% | 17.4% | ||
| Q3 25 | 13.6% | 17.8% | ||
| Q2 25 | 11.4% | 16.8% | ||
| Q1 25 | 2.8% | 17.0% | ||
| Q4 24 | 21.0% | 22.1% | ||
| Q3 24 | 6.3% | 15.2% | ||
| Q2 24 | 18.7% | 15.3% |
资本支出强度OGNROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 3.0% | 0.6% | ||
| Q3 25 | 2.9% | 0.8% | ||
| Q2 25 | 2.4% | 0.7% | ||
| Q1 25 | 2.1% | 0.8% | ||
| Q4 24 | 3.5% | 0.5% | ||
| Q3 24 | 2.7% | 0.8% | ||
| Q2 24 | 2.0% | 1.0% |
现金转化率OGNROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | — | 1.41× | ||
| Q3 25 | 1.65× | 1.17× | ||
| Q2 25 | 1.52× | 1.24× | ||
| Q1 25 | 0.86× | 1.40× | ||
| Q4 24 | 3.58× | 1.78× | ||
| Q3 24 | 0.39× | 1.07× | ||
| Q2 24 | 1.70× | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
